Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.68 -0.07 (-9.16%)
At close: Oct 20, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Revenue (2024 - 2026)

Updated

Scinai Immunotherapeutics (SCNI) posted Revenue of $460,000 for Q2 2026, up 146.0% from $187,000 a year earlier but down 5.9% from the prior quarter.

Analysis

Scinai Immunotherapeutics (SCNI) Revenue (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Scinai Immunotherapeutics was $1.72 million, up 50.1% year-over-year; for FY2025, it was $2.39 million, up 263.1% from FY2024.

  • In prior years, Scinai Immunotherapeutics' Revenue was $658,000 in FY2024.
  • Quarterly Revenue has run from a low of $168,000 in Q3 2024 to a high of $586,000 in Q1 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Scinai Immunotherapeutics 157,066.38 -8.11 Mn -1.25 Mn 460,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 460,000.00
Mar 31, 2026 489,000.00
Jun 30, 2025 187,000.00
Mar 31, 2025 586,000.00
Dec 31, 2024 206,000.00
Sep 30, 2024 168,000.00
API Access

Scinai Immunotherapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=SCNI&period=max&api_key=YOUR_API_KEY